0001209191-18-003469.txt : 20180112 0001209191-18-003469.hdr.sgml : 20180112 20180112181500 ACCESSION NUMBER: 0001209191-18-003469 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180110 FILED AS OF DATE: 20180112 DATE AS OF CHANGE: 20180112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STACK DAVID M CENTRAL INDEX KEY: 0001204788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35060 FILM NUMBER: 18526822 MAIL ADDRESS: STREET 1: THE MEDICINES CO STREET 2: 8 CAMPUS DRIVE CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pacira Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001396814 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510619477 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 300 CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-254-3560 MAIL ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 300 CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: PACIRA INC DATE OF NAME CHANGE: 20080318 FORMER COMPANY: FORMER CONFORMED NAME: Blue Acquisition Corp DATE OF NAME CHANGE: 20070418 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-10 0 0001396814 Pacira Pharmaceuticals, Inc. PCRX 0001204788 STACK DAVID M C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054 1 1 0 0 CEO and Chairman Common Stock 2018-01-10 4 M 0 28885 1.61 A 129331 D Common Stock 2018-01-10 4 S 0 23372 39.96 D 105959 D Common Stock 2018-01-10 4 S 0 4628 41.03 D 101331 D Common Stock 2018-01-10 4 S 0 885 41.97 D 100446 D Common Stock 18596 I By Stack Schroon Mohawk FLP Common Stock 1208 I By LCK Investment LLC Stock Option (Right to Buy) 1.61 2018-01-10 4 M 0 28885 0.00 D 2020-09-02 Common Stock 28885 83190 D The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Includes 167 shares of common stock acquired under the issuer's employee stock purchase plan in December 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.625 to $40.60, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.65 to $41.55, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.70 to $42.25, inclusive. Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC. The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months. /s/ Kristen Williams, Attorney-in-Fact 2018-01-12